Mondelez International, Inc. (MDLZ), headquartered in Chicago, Illinois, manufactures, markets, and sells snack food and beverage products. Valued at $77.9 billion by market cap, the company manufactures and markets iconic global and local brands such as Oreo, Ritz, LU, Clif Bar and Tate's Bake Shop biscuits and baked snacks, as well as Cadbury Dairy Milk, Milka and Toblerone chocolate. The global snacking giant is expected to announce its fiscal fourth-quarter earnings for 2024 on Tuesday, Feb. 4.
Ahead of the event, analysts expect MDLZ to report a profit of $0.67 per share on a diluted basis, down 20.2% from $0.84 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
For the full year, analysts expect MDLZ to report EPS of $3.48, up 9.1% from $3.19 in fiscal 2023. However, its EPS is expected to decline 3.2% year over year to $3.37 in fiscal 2025.
MDLZ stock has considerably underperformed the S&P 500’s ($SPX) 24.4% gains over the past 52 weeks, with shares down 20.9% during this period. Similarly, it underperformed the Consumer Staples Select Sector SPDR Fund’s (XLP) 6.7% gains over the same time frame.
Mondelez International has faced difficulties in keeping up with shifting consumer trends and heightened competition within the snack food sector, resulting in its underperformance.
On Oct. 29, MDLZ shares closed down marginally after reporting its Q3 results. Its adjusted EPS of $0.99 exceeded Wall Street expectations of $0.85. The company’s revenue was $9.2 billion, topping Wall Street forecasts of $9.1 billion.
Analysts’ consensus opinion on MDLZ stock is bullish, with a “Strong Buy” rating overall. Out of 23 analysts covering the stock, 18 advise a “Strong Buy” rating, one suggests a “Moderate Buy,” and four give a “Hold.” MDLZ’s average analyst price target is $78.04, indicating a potential upside of 33.9% from the current levels.
